Related Experiment Videos
Managing inotrope therapy noninvasively
1CardioDynamics International Corporation, San Diego, California, USA.
AACN Clinical Issues
|April 4, 2000
Summary
Thoracic electrical bioimpedance monitoring offers objective data for optimizing inotrope therapy in heart failure patients. This noninvasive method improves drug efficacy assessment and dosage titration, enhancing patient quality of life.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Outpatient inotrope infusions improve quality of life and reduce mortality in end-stage heart failure.
- Historically, inotrope dosing relied on invasive data or subjective patient reports, necessitating hospitalization.
Purpose of the Study:
- To evaluate the utility of thoracic electrical bioimpedance (TEB) in monitoring patients receiving inotrope therapy.
- To determine if TEB provides objective data for dosage titration and efficacy assessment.
Main Methods:
- Utilized thoracic electrical bioimpedance (TEB) for noninvasive hemodynamic monitoring.
- Monitored patients receiving intermittent and continuous outpatient and home inotrope infusions.
Main Results:
- TEB monitoring provides objective data on inotrope efficacy.
- TEB facilitates the assessment of developing drug tolerance.
- TEB aids in determining optimal inotrope dosage.
Conclusions:
- Noninvasive hemodynamic monitoring with TEB is valuable for managing inotrope therapy.
- TEB enables objective assessment of drug response and titration, improving patient care.